A mechanistic approach to explore the neuroprotective potential of zonisamide in seizures
- PMID: 29644555
- DOI: 10.1007/s10787-018-0478-9
A mechanistic approach to explore the neuroprotective potential of zonisamide in seizures
Abstract
Background: Epilepsy, a disease of the brain, is one of the most common serious neurological conditions. It is associated with a group of processes which alter energy metabolism, interrupt cellular ionic homeostasis, cause receptor dysfunction, activate inflammatory cascade, alter neurotransmitter uptake and result in neuronal damage. The increasing knowledge and understanding about the basis of neuronal changes in epilepsy lead to investigate the mechanistic pathway of neuroprotective agents in epilepsy. With this background, the present study is designed to reveal the molecular and biochemical mechanisms involved in the neuroprotective potential of zonisamide in epilepsy.
Methods: Seizure-induced neuronal damage was produced by maximal electroshock seizures in animals. The oxidative stress and neuroinflammatory and apoptotic markers were assessed in the brain tissue of animals.
Results and discussion: The present findings revealed that zonisamide treatment prevented the development of seizures in animals. Seizures-induced free radicals production and neuroinflammation were markedly ameliorated by zonisamide administration. In conclusion, the present study demonstrated the mechanisms behind the strong neuroprotective potential of zonisamide against seizures by attenuating the oxidative stress, inflammatory cascade and neuronal death associated with progression of seizures. It can be further developed as a neuroprotective agent for epilepsy and other neurodegenerative disorders.
Keywords: Cytokines; Epilepsy; Neuroinflammation; Oxidative stress; Seizure; Zonisamide.
Similar articles
-
Zonisamide suppresses endoplasmic reticulum stress-induced neuronal cell damage in vitro and in vivo.Eur J Pharmacol. 2015 Jan 5;746:301-7. doi: 10.1016/j.ejphar.2014.09.023. Epub 2014 Sep 23. Eur J Pharmacol. 2015. PMID: 25261037
-
Clinical pharmacology and mechanism of action of zonisamide.Clin Neuropharmacol. 2007 Jul-Aug;30(4):230-40. doi: 10.1097/wnf.0b013e3180413d7d. Clin Neuropharmacol. 2007. PMID: 17762320 Review.
-
Influence of oral adsorbent AST-120 on anticonvulsive effect of zonisamide in rats.Pharmacol Biochem Behav. 2001 Oct-Nov;70(2-3):375-9. doi: 10.1016/s0091-3057(01)00617-7. Pharmacol Biochem Behav. 2001. PMID: 11701210
-
Pharmacokinetic and pharmacodynamic interaction of hydroalcoholic extract of Ocimum sanctum with valproate.Epilepsy Behav. 2017 Oct;75:203-209. doi: 10.1016/j.yebeh.2017.08.018. Epub 2017 Sep 1. Epilepsy Behav. 2017. PMID: 28867572
-
Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy.Drugs. 1993 May;45(5):760-87. doi: 10.2165/00003495-199345050-00010. Drugs. 1993. PMID: 7686468 Review.
Cited by
-
Zonisamide Ameliorated the Apoptosis and Inflammation in Cerebellar Tissue of Induced Alcohol Addiction Animal Model.Life (Basel). 2024 Jun 24;14(7):795. doi: 10.3390/life14070795. Life (Basel). 2024. PMID: 39063550 Free PMC article.
-
Peri-operative anti-inflammatory drug use and seizure recurrence after resective epilepsy surgery: Target trials emulation.iScience. 2025 Feb 28;28(4):112124. doi: 10.1016/j.isci.2025.112124. eCollection 2025 Apr 18. iScience. 2025. PMID: 40241751 Free PMC article.
-
Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy.J Clin Med. 2021 Jul 30;10(15):3380. doi: 10.3390/jcm10153380. J Clin Med. 2021. PMID: 34362163 Free PMC article.
-
Pentylenetetrazole Induced Kindling Model of Refractory Epilepsy: A Proof-of-concept Study to Explore Dose and Time Range of Phenobarbital in Rats.Basic Clin Neurosci. 2023 Sep-Oct;14(5):701-712. doi: 10.32598/bcn.2022.3904.1. Epub 2023 Sep 1. Basic Clin Neurosci. 2023. PMID: 38628829 Free PMC article.
-
Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy.Curr Neuropharmacol. 2021;19(11):1865-1883. doi: 10.2174/1570159X19666210826125341. Curr Neuropharmacol. 2021. PMID: 34525933 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical